Status | Study |
Completed |
Study Name: Factor XIII and Pulmonary Embolism in Neurosurgical Patients Condition: Brain Tumor Vascular Lesion Factor X Date: 2010-04-16 |
Completed |
Study Name: Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 Condition: Congenital Bleeding Disorder Congenital FXIII Deficiency Date: 2009-09-15 Interventions: Drug: catridecacog Monthly administration of recombinant factor XIII as preventative treatment of bleedi |
Completed |
Study Name: An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency Condition: Factor XIII Deficiency Date: 2009-07-23 Interventions: Biological: FXIII Concentrate (Human) (FXIII) Doses will b |
Completed |
Study Name: A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency Condition: Factor XIII Deficiency Date: 2009-04-21 Interventions: Biological: FXIII Concentrate (Human) Doses will be guided |
Completed |
Study Name: A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency Condition: Factor XIII Deficiency Date: 2009-04-16 Interventions: Biological: FXIII Concentrate (Human) Subjects will receive approximately 40 U/kg of FXIII every 28 days |
Completed |
Study Name: Wound Healing Abnormalities in Major Abdominal Surgery Condition: Impaired Wound Healing Factor XIII Deficiency Date: 2008-08-14 |
Completed |
Study Name: Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency Condition: Congenital Bleeding Disorder Congenital FXIII Deficiency Date: 2008-07-07 Interventions: Drug: catridecacog 35 IU/kg body weight, i.v. administration, once every 4 weeks |
Completed |
Study Name: Clinical Trial of Factor XIII (FXIII) Concentrate Condition: Hemophilia Factor XIII Deficiency Date: 2008-03-17 Interventions: Drug: Fibrogammin P Prophylaxis treatment |
Completed |
Study Name: Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency Condition: Congenital Bleeding Disorder Congenital FXIII Deficiency Date: 2003-03-18 Interventions: Drug: catridecacog Single doses of rFXIII administered intravenously (IV) to two subjects in each of the |